Clinical Trial Results:
Vaccination med peptider deriveret fra anti-apoptotiske proteiner i Bcl-2 familien, administreret i kombination med adjuvant (Montanide ISA-51) i relation til proteasomhæmmerbehandling af patienter med relaps af myelomatose.
En fase I/ II undersøgelse
Summary
|
|
EudraCT number |
2006-003619-29 |
Trial protocol |
DK |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 Sep 2021
|
First version publication date |
25 Sep 2021
|
Other versions |
|
Summary report(s) |
Summary_prematurely ended_LMK |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.